Today: 24 April 2026
Vale Stock Price Today: Shares Fall Despite Iron Ore-From-Waste Milestone
13 March 2026
2 mins read

Vale Stock Price Today: Shares Fall Despite Iron Ore-From-Waste Milestone

SAO PAULO, March 13, 2026, 17:39 BRT

Vale’s U.S.-traded stock dropped roughly 2.5% to $14.68 as of 5:15 p.m. in Sao Paulo on Friday, dulling the impact of the Brazilian miner’s latest operational update. Shares dipped after the company revealed it more than doubled its 2025 iron ore recovery from waste and tailings just a day earlier.

It’s a live question for investors: can Vale’s pitch—cleaner operations, more output—keep pace with rising doubts on iron ore prices and what the stock’s really worth? RBC took the axe to its rating Thursday, arguing Vale’s rally has outstripped BHP and Rio Tinto and is now “fairly priced.” Investing.com

Vale reported its so-called circular mining operations hit 26.3 million metric tons last year, topping the company’s original 20 million-ton outlook and more than doubling the 12.7 million tons logged in 2024. The approach boils down to extracting valuable ore from what used to be waste, such as tailings left behind after the first round of processing. By 2030, Vale aims for 10% of its total output to come from these recycled materials. Since 2023, that initiative has cut disposal by about 60 railcars’ worth of ore and generated over 3 million tons of sand from waste. The strategy has taken on new urgency in Brazil, where deadly dam incidents have forced miners to overhaul tailings management.

Vale is now priced as if iron ore trades around $85 a ton, RBC’s Marina Calero pointed out, a notch above Rio Tinto’s implied $83 and a bit below BHP at $91. Calero bumped her price target up to $15.50, but noted Vale shares have outpaced the sector on the rerating front. RBC’s still looking for a 2026 dividend yield near 8%—almost twice what peers offer—but Calero said that’s not enough juice to keep the bullish call.

The warning from BofA’s Caio Ribeiro actually dates back to late February. At the time, Ribeiro flagged what he called a “mismatch”: Vale shares had climbed 35% year-to-date, yet iron ore prices had slipped 7%. His view—muted steel demand wasn’t offering much in the way of near-term gains for the stock. TipRanks

Sector indicators pointed in different directions. Iron ore touched a two-month peak Thursday after China expanded curbs on certain BHP shipments in the midst of 2026 contract negotiations. On Friday, authorities allowed steelmakers a short window to pick up Jimblebar fines stockpiled at ports. The moves kept supply risk and Chinese appetite in focus, not just Vale’s gains from waste recovery.

Vale steps into the debate with stronger operating results than last year. For 2025, iron ore production hit 336.1 million tons—the company’s best output since 2018—topping Rio Tinto’s Pilbara volumes. Guidance for 2026 remains unchanged, still targeting 335 million to 345 million tons.

Back in February, Chief Executive Gustavo Pimenta said Vale was “focused on operational excellence” and sustainable growth heading into 2026. That statement came as the miner posted fourth-quarter pro forma EBITDA of $4.8 billion—topping analyst estimates—even though a nickel impairment in Canada dragged Vale to a $3.8 billion net loss. Vale

Still, the situation could easily swing the other direction. RBC flagged higher risk for Vale compared to some peers if geopolitical tensions persist, pointing to its cost structure and wider exposure to emerging markets. On top of that, regulatory scrutiny hasn’t faded since January’s overflows, which led to temporary shutdowns at two Vale units. Analysts estimate those units made up around 2% of the company’s 2026 iron ore forecast.

Vale is putting up better volumes and getting the job done more consistently. But on Friday, investors seemed far more focused on where iron ore prices are headed.

Stock Market Today

  • Nuvation Bio (NUVB) Share Price Surges Amid Mixed Valuation Signals
    April 23, 2026, 11:58 PM EDT. Nuvation Bio's stock rose 4.8% over the past week and 17.8% over 30 days, despite a 41.3% year-to-date decline. The company's drug development progress has spurred investor interest. A Discounted Cash Flow (DCF) analysis shows the stock could be undervalued by 86.7%, with an intrinsic value of about $38 per share versus the current $5.04 price. However, valuation using the Price-to-Sales (P/S) ratio paints a different picture; Nuvation Bio trades at 27.86x sales, significantly higher than the Pharmaceuticals industry average of 4.88x and peer average of 11.51x. The contrasting signals highlight uncertainty about the stock's fair value. Investors should weigh the company's pipeline updates carefully amid these divergent valuation metrics.

Latest article

Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

24 April 2026
Newmont reported adjusted first-quarter earnings of $2.90 per share on $7.31 billion in sales, beating estimates as realized gold prices surged to $4,900 an ounce. Attributable gold output fell to 1.30 million ounces from 1.54 million a year earlier. The miner declared a $0.26 dividend and authorized a new $6 billion share buyback. Newmont expects higher costs and lower output in the second quarter.
SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

24 April 2026
SAP reported a 17% rise in first-quarter operating profit to 2.74 billion euros and a 19% jump in cloud revenue to 5.96 billion euros, beating forecasts. The company kept its 2026 targets and full-year outlook unchanged. SAP’s U.S. shares reversed losses after the results, climbing nearly 7% in after-hours trading. Management warned cloud revenue growth will slow in the second quarter.
MaxLinear Stock Surges as AI Data-Center Chip Demand Drives Big Q2 Outlook

MaxLinear Stock Surges as AI Data-Center Chip Demand Drives Big Q2 Outlook

24 April 2026
MaxLinear forecast second-quarter revenue of $160 million to $170 million, well above Wall Street’s estimate of $137.1 million. First-quarter revenue rose 43% to $137.2 million, driven by demand for optical products in AI data centers. Shares surged over 23% to $42.47 in after-hours trading. Infrastructure revenue jumped 136% from a year earlier, becoming the company’s largest segment.
Pfizer Stock Price Today: Shares Slip After GSK RSV Move Offsets Eliquis Data
Previous Story

Pfizer Stock Price Today: Shares Slip After GSK RSV Move Offsets Eliquis Data

Why Amazon Stock Price Is Slipping Despite a Court Win and New AI Deal
Next Story

Why Amazon Stock Price Is Slipping Despite a Court Win and New AI Deal

Go toTop